A newly identified circular RNA molecule is rewriting our understanding of the inflammatory storm that follows a heart attack, offering a potential dual-purpose tool for both predicting patient outcomes and guiding future therapies. In a study published in Cell Death Discovery, researchers have shown that a specific circRNA, dubbed CircTMCC1, acts as a master regulator of mitochondrial collapse and immune cell polarization in acute myocardial infarction, and its levels closely mirror the functional severity of coronary blockages as measured by a state-of-the-art imaging technique.
The aftermath of a myocardial infarction is a race between tissue repair and destructive inflammation. Central to this process are macrophages, immune cells that can adopt a helpful tissue-healing M2 phenotype or a harmful pro-inflammatory M1 state. When the balance tips too far toward M1 polarization, it exacerbates cardiac injury, enlarges the infarct scar, and accelerates heart failure. The molecular triggers behind this dangerous shift have remained incompletely charted, making the discovery of CircTMCC1 a significant leap forward. The team, led by Ren and colleagues, detected a sharp upregulation of this circular RNA in both mouse models of cardiac ischemia and in blood samples from human patients shortly after a heart attack.
CircTMCC1 exerts its damage through a double-barreled assault. On one front, it infiltrates the mitochondrial power plants of macrophages, where it disrupts the organelle’s membrane potential and cripples oxidative phosphorylation. The result is a cellular energy crisis accompanied by a flood of reactive oxygen species, a classic signature of mitochondrial dysfunction that is known to prime inflammatory pathways. On a parallel track, the circRNA hijacks a crucial metabolic signaling node: the AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) cascade. By suppressing AMPK activity, CircTMCC1 releases the brakes on mTOR, which in turn phosphorylates downstream effectors that commit macrophages to the inflammatory M1 lineage, locking them into a state of sustained cytokine release.
The mechanistic precision is striking. Through a series of loss- and gain-of-function experiments, the researchers demonstrated that silencing CircTMCC1 in cultured macrophages restored mitochondrial respiration, lowered oxidative stress, and recalibrated the AMPK/mTOR axis, effectively shrinking the population of M1 cells while boosting M2 markers. In living organisms, injecting a CircTMCC1-targeting short hairpin RNA into mice subjected to experimental infarction not only reduced the size of the necrotic heart muscle by nearly 40 percent but also preserved left ventricular ejection fraction, a key measure of the heart’s pumping capacity. These functional gains were accompanied by histological evidence of diminished macrophage infiltration and a more favorable M2-skewed environment.
Perhaps most compelling for translational medicine is the link the study draws between CircTMCC1 and Quantitative Flow Ratio (QFR) assessment. QFR is a non-invasive computational method that reconstructs three-dimensional coronary artery geometry from standard angiograms to calculate the pressure drop across a stenosis, providing a functional index of ischemia without the need for a pressure wire. In a cohort of acute myocardial infarction patients, the team found that circulating levels of CircTMCC1 correlated strongly with post-procedural QFR values. Patients with higher circRNA loads exhibited worse microvascular function and higher residual pressure gradients, even after the culprit lesion was stented. This positions CircTMCC1 as a potential liquid biopsy biomarker that could refine risk stratification at a stage when traditional anatomical parameters fall short.
The convergence of mitochondrial biology, macrophage immunometabolism, and advanced coronary physiology is what sets this work apart. It reframes the early post-infarction period as a window during which a single molecular entity, CircTMCC1, orchestrates both the cellular energy collapse and the immune switch that drives secondary tissue injury. The AMPK/mTOR connection is especially intriguing because drugs that modulate this pathway, including metformin and rapamycin analogs, are already in clinical use, raising the possibility of repurposing them to curb CircTMCC1-mediated damage if the circRNA’s upstream regulatory factors can be identified.
Yet challenges remain. The upstream signals that trigger CircTMCC1 overexpression following ischemia are still unknown, and delivering RNA therapeutics specifically to cardiac macrophages in a clinical setting is a formidable hurdle. The authors acknowledge that larger, multicenter studies will be needed to validate the QFR-associated biomarker utility across diverse populations and infarct types. Nevertheless, by illuminating a circuitry where a circular RNA links mitochondrial failure to a maladaptive immune response, the study opens multiple therapeutic frontlines: targeting CircTMCC1 itself, intercepting its mitochondrial effects, or pharmacologically resetting the AMPK/mTOR balance. In an era where heart disease remains the world’s leading killer, any fresh molecular handle that can both diagnose and direct treatment is a highly welcome signal amid the noise.
Subject of Research: Regulation of acute myocardial infarction by CircTMCC1 through mitochondrial dysfunction and AMPK/mTOR-driven M1 macrophage polarization, and its correlation with QFR assessment.
Article Title: Heart Attack’s Hidden Conductor: Circular RNA Hijacks Mitochondria and Immune Cells
Article References:
Ren, M., He, S., Duan, M. et al. Regulation of acute myocardial infarction by CircTMCC1 through mitochondrial dysfunction and AMPK/mTOR-driven M1 macrophage polarization: role in QFR assessment.
Cell Death Discov. (2026). https://doi.org/10.1038/s41420-026-03213-9
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41420-026-03213-9
Keywords: acute myocardial infarction, CircTMCC1, mitochondrial dysfunction, AMPK/mTOR signaling, M1 macrophage polarization, Quantitative Flow Ratio (QFR), circular RNA, immunometabolism
